samarium has been researched along with etidronate in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Curley, T; Larson, S; O'Moore, PV; Scher, HI; Tong, W; Yeh, S | 1 |
| Ketring, AR | 1 |
| McEwan, AJ | 1 |
| Lewington, VJ | 1 |
| Atkins, HL; Srivastava, SC | 1 |
| Brenner, W; Henze, E; Kampen, AM; Kampen, WU | 1 |
| de Klerk, JM; Hoekstra, A; Lam, MG; van Rijk, PP; Zonnenberg, BA | 1 |
3 review(s) available for samarium and etidronate
| Article | Year |
|---|---|
Hormone refractory prostatic cancer: the role of radiolabelled diphosphonates and growth factor inhibitors.
Topics: Animals; Bone Neoplasms; Dogs; Drug Screening Assays, Antitumor; Etidronic Acid; Growth Substances; Humans; Male; Neoplasm Proteins; Organometallic Compounds; Organophosphorus Compounds; Palliative Care; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Rhenium; Samarium; Suramin | 1992 |
Targeted radionuclide therapy for bone metastases.
Topics: Analgesics; Bone Neoplasms; Combined Modality Therapy; Etidronic Acid; Humans; Organometallic Compounds; Organophosphorus Compounds; Pain, Intractable; Palliative Care; Radioisotopes; Radiotherapy; Rhenium; Samarium; Strontium Radioisotopes | 1993 |
Radiolabeled bone-seeking radiopharmaceuticals.
Topics: Animals; Bone Neoplasms; Etidronic Acid; Female; Humans; Male; Pentetic Acid; Radioisotopes; Radiopharmaceuticals; Rhenium; Samarium; Tin | 1996 |
1 trial(s) available for samarium and etidronate
| Article | Year |
|---|---|
Hormone refractory prostatic cancer: the role of radiolabelled diphosphonates and growth factor inhibitors.
Topics: Animals; Bone Neoplasms; Dogs; Drug Screening Assays, Antitumor; Etidronic Acid; Growth Substances; Humans; Male; Neoplasm Proteins; Organometallic Compounds; Organophosphorus Compounds; Palliative Care; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Rhenium; Samarium; Suramin | 1992 |
4 other study(ies) available for samarium and etidronate
| Article | Year |
|---|---|
153Sm-EDTMP and 186Re-HEDP as bone therapeutic radiopharmaceuticals.
Topics: Animals; Bone Neoplasms; Dogs; Etidronic Acid; Humans; Kinetics; Organophosphorus Compounds; Pain; Rabbits; Radioisotopes; Radionuclide Imaging; Rhenium; Samarium; Technetium Tc 99m Medronate; Tissue Distribution | 1987 |
Pain palliation and nuclear medicine.
Topics: Bone Neoplasms; Etidronic Acid; Humans; Organometallic Compounds; Organophosphorus Compounds; Pain, Intractable; Palliative Care; Radioisotopes; Rhenium; Samarium; Strontium Radioisotopes | 1993 |
Skeletal uptake and soft-tissue retention of 186Re-HEDP and 153Sm-EDTMP in patients with metastatic bone disease.
Topics: Aged; Bone and Bones; Bone Neoplasms; Etidronic Acid; Female; Humans; Male; Middle Aged; Muscle, Skeletal; Organometallic Compounds; Organophosphorus Compounds; Pain Management; Palliative Care; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Samarium; Thigh; Urinary Bladder | 2001 |
Radiation safety considerations for the bone seeking radiopharmaceuticals. 89SrCl2, 186Re-HEDP and 153Sm-EDTMP.
Topics: Adult; Aged; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Etidronic Acid; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Organometallic Compounds; Organophosphorus Compounds; Prostatic Neoplasms; Radiation Injuries; Radioisotopes; Rhenium; Safety; Samarium; Strontium; Strontium Radioisotopes | 2009 |